Goldman Sachs’s Sarepta Therapeutics SRPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $6.43M | Buy |
|
|||||
|
2025
Q1 | $11.6M | Sell |
|
|||||
|
2024
Q4 | $58M | Buy |
|
|||||
|
2024
Q3 | $37.6M | Sell |
|
|||||
|
2024
Q2 | $69.5M | Buy |
|
|||||
|
2024
Q1 | $32.4M | Buy |
|
|||||
|
2023
Q4 | $17.8M | Sell |
|
|||||
|
2023
Q3 | $90.1M | Sell |
|
|||||
|
2023
Q2 | $111M | Buy |
|
|||||
|
2023
Q1 | $104M | Sell |
|
|||||
|
2022
Q4 | $161M | Buy |
|
|||||
|
2022
Q3 | $126M | Sell |
|
|||||
|
2022
Q2 | $106M | Buy |
|
|||||
|
2022
Q1 | $72.2M | Sell |
|
|||||
|
2021
Q4 | $90.6M | Buy |
|
|||||
|
2021
Q3 | $80.7M | Sell |
|
|||||
|
2021
Q2 | $69.2M | Buy |
|
|||||
|
2021
Q1 | $53.2M | Sell |
|
|||||
|
2020
Q4 | $179M | Sell |
|
|||||
|
2020
Q3 | $176M | Buy |
|
|||||
|
2020
Q2 | $201M | Sell |
|
|||||
|
2020
Q1 | $130M | Buy |
|
|||||
|
2019
Q4 | $143M | Buy |
|
|||||
|
2019
Q3 | $77.4M | Buy |
|
|||||
|
2019
Q2 | $85.5M | Sell |
|
|||||
|
2019
Q1 | $80.2M | Buy |
|
|||||
|
2018
Q4 | $69M | Buy |
|
|||||
|
2018
Q3 | $86.8M | Sell |
|
|||||
|
2018
Q2 | $110M | Buy |
|
|||||
|
2018
Q1 | $50.6M | Sell |
|
|||||
|
2017
Q4 | $41.2M | Buy |
|
|||||
|
2017
Q3 | $30.2M | Sell |
|
|||||
|
2017
Q2 | $27.4M | Buy |
|
|||||
|
2017
Q1 | $15.8M | Buy |
|
|||||
|
2016
Q4 | $6.54M | Sell |
|
|||||
|
2016
Q3 | $17.4M | Sell |
|
|||||
|
2016
Q2 | $8.42M | Buy |
|
|||||
|
2016
Q1 | $2.24M | Buy |
|
|||||
|
2015
Q4 | $575K | Sell |
|
|||||
|
2015
Q3 | $841K | Sell |
|
|||||
|
2015
Q2 | $3.25M | Buy |
|
|||||
|
2015
Q1 | $787K | Sell |
|
|||||
|
2014
Q4 | $1.26M | Buy |
|
|||||
|
2014
Q3 | $490K | Sell |
|
|||||
|
2014
Q2 | $1.16M | Buy |
|
|||||
|
2014
Q1 | $533K | Buy |
|
|||||
|
2013
Q4 | $139K | Sell |
|
|||||
|
2013
Q3 | $422K | Sell |
|
|||||
|
2013
Q2 | $5.54M | Buy |
|